Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Clinical Pathways GPS

Clinical Pathways Guiding Where and When

09/19/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...

...

09/19/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Truly Patient-Centered Clinical Pathways

08/16/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Scott Guerin , PhD;

For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...

For...

08/16/2017

Journal of Clinical Pathways

Clinical Pathways GPS

The New FDA and Its Impact on Clinical Pathways

06/14/2017

Scott Guerin , PhD;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...

...

06/14/2017

Journal of Clinical Pathways

Clinical Pathways GPS

The Next 1361 Days and How They Will Impact Clinical Pathways

05/12/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...

Over...

05/12/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Preparing for Take-Off: Readying Older Adults for Flight

04/11/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Sevy Gambs , MBA, ALA, MSN-GR;

Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...

Older...

04/11/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Developing Balanced Clinical Pathways Through Individualized Care

03/15/2017

Terri L. Schieder , RN, MS, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Clinical pathways should address all three aspects of the Triple Aim, but the aim of improving population health often is prioritized at the expense of improving the patient experience of care and reducing the cost...

...

03/15/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Going Beyond Multiple Sclerosis Treatments to Address Problematic Symptoms

12/13/2016

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Nader Tavakoli , MD, CMD, FAAFP;

Aysha Khan , MD;

Multiple sclerosis (MS) is a disabling condition that is managed medically through an ever growing list of pharmaceutical treatments. Clinical pathways that focus primarily on treatments for the disease overlook...

...

12/13/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Sites of Care: An Opportunity to Address Efficiency and Effectiveness in Clinical Pathways

11/15/2016

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

As our health system increases the financial responsibility of health care providers, there is increased focus among these providers on reducing costs. Part of this cost-reduction effort involves improving the...

As our...

11/15/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Hitting Each Component of the Triple Aim Along the Clinical Pathway

05/06/2016

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Seth Gordon , MBA;

Scott Guerin , PhD;

The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...

The...

05/06/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Adding Patient Navigation to the Clinical Pathway for Alzheimer Disease

04/11/2016

Ruth Gay ;

David Digby ;

Harold Freeman , MD;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Mary Michael ;

Patient navigation has proven capable of both improving health outcomes and decreasing costs to the health care system. Although the use of patient navigation in the context of cancer care has been described...

...

04/11/2016

Journal of Clinical Pathways